Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3D Global BiotechROCO:6808 -3.00%70 Interest Coverage is 17.53 as of Dec. 2025, which is 100% below its 10-year median of 5,382.34. GuruFocus rates ROCO:6808 with a GF Score™ of 70/100 and a GF Value™ of NT$185.91 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 376 Biotechnology companies, 3D Global Biotech ranks worse than 61.44% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. 3D Global Biotech's
Operating Income
for the
six
months ended in Dec. 2025 was NT$9.7 Mil. 3D Global Biotech's Interest Expense for the
six
months ended in Dec. 2025 was NT$-0.6 Mil.
3D Global Biotech's interest coverage for the quarter that ended in Dec. 2025 was 17.53.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for 3D Global Biotech's Interest Coverage or its related term are showing as below:
ROCO:6808'
s Interest Coverage Range Over the Past 10 Years
Min: 31.56 Med: 5382.34 Max: No Debt
Current: 31.56
ROCO:6808's Interest Coverage is ranked worse than 61.44% of 376
companies
in the Biotechnology industry
Industry Median: 104.025
vs ROCO:6808: 31.56
3D Global Biotech (ROCO:6808) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
3D Global Biotech Interest Coverage Related Terms
3D Global Biotech Interest Coverage Historical Data
* Premium members only.
The historical data trend for 3D Global Biotech's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
ROCO:6808 vs VRTX, REGN, ALNY: Interest Coverage Comparison
For the Biotechnology subindustry, 3D Global Biotech's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
3D Global Biotech Interest Coverage vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, 3D Global Biotech's Interest Coverage distribution charts can be found below:
* The bar in red indicates where 3D Global Biotech's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
3D Global Biotech (ROCO:6808) has a Interest Coverage of 17.53 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on 3D Global Biotech and its competitors. This is 100% below median its historical median of 5,382.34. Over the past decade, 3D Global Biotech's Interest Coverage has ranged from 31.56 to 10,000.00. According to the industry distribution chart, 3D Global Biotech ranks #231 out of 376 companies in the Biotechnology industry, placing it in the top 61.4%.
Is 3D Global Biotech's Interest Coverage too high?
3D Global Biotech's current Interest Coverage of 17.53 is 100% below median its 10-year median of 5,382.34. Over the past 10 years, this metric has ranged from a low of 31.56 to a high of 10,000.00. The Biotechnology industry median Interest Coverage is 104.03. 3D Global Biotech's value of 17.53 is 83.1% below this industry median. Based on the distribution chart, 3D Global Biotech ranks #231 out of 376 companies in the Biotechnology industry, which is below the industry midpoint. Overall, 3D Global Biotech has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does 3D Global Biotech's Interest Coverage compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, 3D Global Biotech ranks #231 out of 376 companies for Interest Coverage. This places 3D Global Biotech in the lower half of its industry. The industry median Interest Coverage is 104.03. 3D Global Biotech's value of 17.53 is 83.1% below this benchmark. Historically, 3D Global Biotech's own Interest Coverage has ranged from 31.56 to 10,000.00 over the past decade. While the company's 10-year median is 5,382.34 vs. the industry median of 104.03, 3D Global Biotech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Biotechnology company?
The median Interest Coverage among Biotechnology companies is 104.03, based on 376 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 3D Global Biotech's current Interest Coverage of 17.53 is 83.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on 3D Global Biotech and its competitors. For the Biotechnology industry, the median Interest Coverage is 104.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 3D Global Biotech's current Interest Coverage is 17.53, which is 100% below median its own 10-year median of 5,382.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 3D Global Biotech stock overvalued right now?
Based on GuruFocus' analysis, 3D Global Biotech (ROCO:6808) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$185.91, compared to a current price of NT$38.85 — trading 79.1% below its estimated fair value. The current Interest Coverage is 17.53, which is 100% below median its 10-year median of 5,382.34 and 83.1% below the Biotechnology industry median of 104.03. 3D Global Biotech's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For 3D Global Biotech (ROCO:6808), the current Interest Coverage is 17.53 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 3D Global Biotech (ROCO:6808) Overvalued in 2026?
Based on GuruFocus' analysis, 3D Global Biotech stock appears to be undervalued.
The current stock price of NT$38.85 is trading 79.1% below its estimated GF Value™ of NT$185.91.
GuruFocus considers 3D Global Biotech to be Significantly Undervalued.
Key valuation signals for ROCO:6808:
Interest Coverage: 17.53 (100% below median its 10-year median of 5,382.34)
GF Value™: NT$185.91 vs. price of NT$38.85 (79.1% below fair value)
Industry Position: 83.1% below the Biotechnology median (#231 of 376)
No single metric tells the full story. See the ROCO:6808 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
3D Global Biotech Inc is engaged in the research and development of high-end medical equipment and biological 3D printing technology and the sale of medical Materials and other related products.
70GF Score
Get the complete analysis for ROCO:6808
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6808 has been successfully added to your 
